364 filings
Page 3 of 19
6-K
8lizl21v7r1k05fghk
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
u560qtbfv8wfa4cdah22
5 Jul 22
Current report (foreign)
6:02am
6-K
d2xt76c 3txhnhk
28 Jun 22
BioLineRx Announces Collaboration Agreement with GenFleet Therapeutics to Further Develop Motixafortide in
7:14am
6-K
5ej5hq0 9i
16 Jun 22
BioLineRx Announces Appointment of Commercial Strategy
7:05am
6-K
ht1 bvfp9
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
5bloszhhk0ozh8eo5
11 May 22
BioLineRx Reports First Quarter 2022 Financial Results
7:14am
6-K
yk4e2h3
16 Mar 22
BioLineRx Reports Fourth Quarter 2021 Financial Results
7:11am
6-K
sx49ed0jb2nh1 mo
3 Mar 22
BioLineRx Announces Additional Positive Results from
7:10am
6-K
fqceshz4j
24 Jan 22
BioLineRx Announces Completion of Enrollment of Phase 1/2a
7:11am
6-K
nyav8tlm2l70bm xx8
18 Jan 22
BioLineRx Announces Successful Completion of Pre-NDA
7:11am
6-K
xo7i 8gtie7z4ih3wef
17 Dec 21
BioLineRx Provides Highlights from Oral Presentation
7:10am
6-K
gifjhxuw
15 Dec 21
BioLineRx Announces Formation of Immuno-Oncology
7:25am
6-K
bv041ukz
3 Dec 21
Current report (foreign)
4:30pm
6-K
kbzwuc661z7vzt
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
kk03xvuif y7x
4 Nov 21
BioLineRx Announces an Oral Presentation and Three
10:15am
6-K
esmwbqhx 497pq38
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
0rug8u1c f2fy3v43e
13 Oct 21
BioLineRx Announces Positive Results from
8:37am
6-K
fvo 5oy9tc6
3 Sep 21
Current report (foreign)
4:30pm
6-K
irmqwrtewahi6f
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
lz408scoaaewz6z4m
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am